PB1793: NEUTROPHIL TO LYMPHOCYTE RATIO AS A PROGNOSTIC FACTOR IN AML AND MDS
Main Authors: | V. Van Oorschot, M. Beckers |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-06-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/01.HS9.0000850024.01897.d8 |
Similar Items
-
Inherited predisposition to MDS/AML
by: Ana Rio Machin, et al.
Published: (2018-06-01) -
Telomere length is an independent prognostic marker in MDS but not in de novo AML
by: Williams, J, et al.
Published: (2017) -
PB2296: THE PROGNOSTIC ROLE OF NEUTROPHIL TO LYMPHOCYTE RATIO AND PLATELET TO LYMPHOCYTE RATIO IN COVID-19 PATIENTS: A MONOCENTRIC STUDY
by: W. Boufrikha, et al.
Published: (2022-06-01) -
Breast cancer prognostication with neutrophil–lymphocyte ratio and platelet–lymphocyte ratio
by: Taha Bahgat
Published: (2017-01-01) -
Neutrophil to Lymphocyte Ratio in Retroperitoneal Liposarcoma and Other Prognostic Factors
by: FU Yali, et al.
Published: (2019-02-01)